Targeting different types of human meningioma and glioma cells using a novel adenoviral vector expressing GFP-TRAIL fusion protein from hTERT promoter
Jessica T. Li(The University of Texas MD Anderson Cancer Center), Ferid Murad(Stanford Blood Center), Rahul K. Nath(Texas Nerve and Paralysis Institute), Ian E. McCutcheon(The University of Texas MD Anderson Cancer Center), Alan Zhang(The University of Queensland), Ka Bian(Nanjing Normal University), William W. Ashley(Sinai Hospital), Dong Kim(Seoul National University), Bingliang Fang(The University of Texas MD Anderson Cancer Center)
Cited by 13
Related Papers
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k
Cyclic guanosine monophosphate as a mediator of vasodilation.
|Journal of Clinical Investigation|1986|808
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
|Endocrine Related Cancer|2017|357
Expression of insulin growth factor‐1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation
|The Journal of Physiology|1999|281
Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to <i>TGFBR1</i> or <i>TGFBR2</i> mutations
|Journal of Medical Genetics|2009|187